-
SimBioSys secures third US FDA 510(k) clearance for its TumorSight Viz to advance AI─powered precision surgery in breast cancer care
11 Jul 2025 12:01 GMT
… in the fight against breast cancer," said Stacey … , and efficiency in breast cancer surgery. With its third … outcomes are transforming breast cancer care. Re-excision … data-driven approaches. The National Comprehensive Cancer Network (NCCN) supports this …
-
Simbiosys Secures Third FDA Clearance For Tumorsighttm Viz, Advancing AI-Powered Precision Surgery In Breast Cancer Care
09 Jul 2025 17:46 GMT
… 5 The National Comprehensive Cancer Network (NCCN) … in breast cancer patients. npj Breast Cancer.
Pekis … lumpectomy for breast cancer: Addressing … National Comprehensive Cancer Network (NCCN). (2024). NCCN Clinical Practice Guidelines in Oncology: Breast Cancer …
-
Screening, Prehab May Reduce Breast Cancer Survivorship Burden
08 Jul 2025 15:06 GMT
… of care.
Guidelines from National Comprehensive Cancer Network (NCCN) and the National … the physical side effects of breast cancer treatment, implementation remains inconsistent … demonstrated successful management of breast cancer-related lymphedema using a …
-
Advancements in Dalpiciclib for the Treatment of Breast Cancer Patients: A Review
30 Jun 2025 09:58 GMT
… breast cancer (MBC) and ABC patients by the National Comprehensive Cancer Network … breast cancer therapy. Given the variations in breast cancer … 2305 breast tumours. Breast Cancer Res … breast cancer receiving first-line ribociclib plus fulvestrant. Breast Cancer …
-
29 A Real-World Exploratory Analysis to Identify Disparities in Breast Cancer Tumor Biopsy Practice at Community Oncology Clinics in the United States
18 Jun 2025 02:21 GMT
… National Comprehensive Cancer Network (NCCN) guidelines recommend that all breast cancer … metastatic breast cancer patients … at metastatic breast cancer diagnosis. … breast cancer. Performance status and disease-related parameters at metastatic breast cancer …
-
Understanding the Importance of the DESTINY-Breast09 Trial in HER2+ Breast Cancer
17 Jun 2025 22:09 GMT
… with metastatic HER2-positive positive breast cancer,” Tolaney explained.
In the … 15% to 20% of all breast cancers are HER2-positive, and outcomes … see future changes in the National Comprehensive Cancer Network (NCCN) Guidelines.
Certainly, patients can …
-
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
10 Jun 2025 23:10 GMT
… -positive (ER+) lobular breast cancer, the updated National Comprehensive Cancer Network (NCCN) Guidelines recommendation … lobular breast cancer.
“ … Over 90 percent of lobular breast cancers over … For ER-positive lobular breast cancers, this FES PET scan …
-
Breast Cancer Targeted Therapies and Guidelines, Part 2
03 Jun 2025 00:55 GMT
… in breast cancer treatment.
Breast Cancer Targeted … breast cancer, especially in HR-positive breast cancer and HER2-positive breast cancer … NCCN is the National Comprehensive Cancer Network.
References:
The … HER2-positive breast cancers, adjuvant trastuzumab …
-
Camizestrant reduced the risk of disease progression or death by 56% in patients with advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial
01 Jun 2025 12:10 GMT
…
HR-positive breast cancer
Breast cancer is the … Estrogen receptor positive breast cancers have patient specific … 5):821-30.
National Comprehensive Cancer Network. Clinical Practice Guidelines … hormone receptor‑positive breast cancer. Breast Cancer Res. 2021; …
-
Guidelines Recommend Use of FES PET Imaging for Lobular Breast Cancer
30 May 2025 21:23 GMT
… ER+) breast cancer metastases, including lobular breast cancer. The … ER+ breast cancer.
According to the Breast Cancer Research … breast cancer in the U.S., accounting for 10-15% of all breast cancers … imaging.
The National Comprehensive Cancer Network (NCCN) is …
About
© 1995-2025